When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 44 Hits
  • Search Condition : Filter (MeSH = Pancreatic Neoplasms / metabolism)
Species Resource Title
Human and Animal Cells A549(RCB0098) Rho-Associated Protein Kinase (ROCK) Inhibitors Inhibit Survivin Expression and Sensitize Pancreatic Cancer Stem Cells to Gemcitabine.
DNA material , Human and Animal Cells mitoKeima-Red (RDB18369) , PANC-1(RCB2095), A549 Glycolytic suppression dramatically changes the intracellular metabolic profile of multiple cancer cell lines in a mitochondrial metabolism-dependent manner.
Human and Animal Cells HS-K(RCB0159) Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice.
Human and Animal Cells CACO-2(RCB0988) , LoVo(RCB1639) , MKN1(RCB1003) , MKN7(RCB0999) , MKN45(RCB1001) , MKN74(RCB1002) Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.
Human and Animal Cells C6(RCB2854) Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models.
Human and Animal Cells RGC-6(RCB2783) Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Human and Animal Cells KLM-1(RCB2138) , KP4-3(RCB1008) , PK-1(RCB1972) , PK-45H(RCB1973) MDH1 and MPP7 Regulate Autophagy in Pancreatic Ductal Adenocarcinoma.
Human and Animal Cells hPSC5 Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.
Human and Animal Cells DAUDI(RCB1640) PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis.
Human and Animal Cells MCF7(RCB1904) , PANC-1(RCB2095) , MIA Paca2(RCB2094) , HCT116(RCB2979) , Hep G2 , HeLa Silencing of Glutathione S-Transferase Pi Inhibits Cancer Cell Growth via Oxidative Stress Induced by Mitochondria Dysfunction.
Human and Animal Cells PANC-1(RCB2095) Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
Human and Animal Cells PANC-1(RCB2095) S100P regulates the collective invasion of pancreatic cancer cells into the lymphatic endothelial monolayer.
Human and Animal Cells MIA Paca2(RCB2094) Nab-paclitaxel interrupts cancer-stromal interaction through C-X-C motif chemokine 10-mediated interleukin-6 downregulation in vitro.
Human and Animal Cells MIA Paca2(RCB2094) Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion.
Human and Animal Cells PK-59(RCB1901) Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancer.
Human and Animal Cells LC-2/ad(RCB0440) MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.
Human and Animal Cells PANC-1(RCB2095) Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis.
Human and Animal Cells PK-8(RCB2700) Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Human and Animal Cells Onartuzumab (MetMAb): using nonclinical pharmacokinetic and concentration-effect data to support clinical development.